Landsec books nearly £200m loss as it shrinks presence in London November 15, 2022 British property investment trust Land Securities, known as Landsec, has booked a nearly £200m loss over the past six months as interest rates sting. It follows a £275m profit in the same period last year, as the company retreats out of London. Landsec, one of the largest office leasers in London, has cut the capital’s [...]
Defence giant BAE Systems secures £28bn worth of orders so far this year November 15, 2022 BAE Systems, one of the largest defence companies in the UK, has secured £10bn worth of orders in the second half of this year so far. The London-listed defence firm, which builds military-grade jets, submarines and satellites, has kept its guidance in place while many businesses in the UK nudge them lower amid the economic [...]
OakNorth boss: Government must lure investors to lock-in homegrown tech firms November 14, 2022 The government must lure investors to the UK if it is to lock-in homegrown tech firms, the co-founder of London-based fintech OakNorth has said. London, which was today overtaken by Paris as Europe’s biggest stock market, has been “having a tough time convincing technology companies to list here,” Rishi Khosla wrote in The Times today. [...]
British battery firm Zenobe to invest £750m in diversifying UK energy grid November 14, 2022 British battery-storage firm Zenobe has tabled plans to invest £750m into the UK’s bid to diversify its energy grid. The company is looking to build three large battery projects in Scotland between 2024 and 2026, Bloomberg first reported, which would boost wind power resources in the countries. The UK is hoping to more than triple [...]
AstraZeneca’s battle against cancer knocks on door of EU with three new drugs November 14, 2022 AstraZeneca, the pharmaceutical giant behind one of the world’s first Covid-19 vaccines, has had three new cancer drugs recommended for approval in the European Union. The FTSE 100 pharma firm said its drug Imfinzi – for uses against biliary tract cancer alongside chemotherapy, gastric cancer medicine Enhertu and prostate cancer treatment Lynparza, in combination with [...]
US pharma giants to merge under $145m deal to tackle opioid overdose epidemic November 14, 2022 Indivior, a US pharmaceutical heavyweight, has bought addiction and overdose treatment competitor Opiant Pharmaceuticals for $145m (£123m) The FTSE 250 pharma firm is coughing up some $20.00 per share in cash upfront, Indivior said in a statement today. Plus, a further $8.00 a piece should revenue milestones be achieved over the next seven years. Both [...]
Roche shares dip as hope for long-awaited Alzheimer’s drug quickly fades November 14, 2022 Shares in Swiss pharmaceutical giant dipped today after disappointing results from its late-stage Alzheimer’s drug. The drug, known as Gantenerumab, was seen as a high-risk but high-reward drug, according to Sebastian Skeet, senior healthcare analyst at investment research firm Third Bridge. However, the treatment failed to slow the progression of dementia across two ongoing trials. [...]
Wood Group forks out £97m to settle historic litigation case November 14, 2022 John Wood Group and its energy subsidiary Amec Foster Wheeler Energy are to fork out $115m (£97.6m) to settle a legacy litigation case with US energy services provider Enterprise. All parties have agreed on the settlement fee, which will be paid in one instalment within the next week, Wood Group announced this morning. Enterprise filed [...]
Mike Ashley’s Frasers in late stage talks for Gieves & Hawkes takeover November 14, 2022 Frasers Group is reportedly in late stage talks to seal a deal for Gieves & Hawkes, a beleaguered tailor which previously dressed Sir Winston Churchill and Queen Elizabeth II. Mike Ashley’s empire is swooping in for the Savile Row retailer after its Hong Kong-based owner fell into administration, Sky News first reported. The popularity of [...]
The Works sales boosted by return to school despite cost of living crisis November 11, 2022 Arts and crafts chain The Works has seen sales increase in the past six months despite the cost of living crisis, carried by a “record” ‘back to school’ season. Brits splashed the cash on new stationary for their children this year, according to The Works’ latest trading update. The cost of living crisis does not [...]